CRH Medical Corp (CRHM) Receives $5.92 Average PT from Analysts

CRH Medical Corp (NYSEAMERICAN:CRHM) has been given a consensus rating of “Buy” by the ten analysts that are currently covering the firm, MarketBeat Ratings reports. Four equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. The average 1 year price target among analysts that have issued ratings on the stock in the last year is $7.50.

Separately, Zacks Investment Research lowered shares of CRH Medical from a “buy” rating to a “hold” rating in a research report on Monday, January 15th.

How to Become a New Pot Stock Millionaire

Institutional investors and hedge funds have recently modified their holdings of the company. Vanguard Group Inc. acquired a new position in shares of CRH Medical in the second quarter valued at about $150,000. Mawer Investment Management Ltd. grew its stake in shares of CRH Medical by 25.7% in the third quarter. Mawer Investment Management Ltd. now owns 5,963,519 shares of the company’s stock valued at $15,542,000 after acquiring an additional 1,221,028 shares in the last quarter. TD Asset Management Inc. grew its stake in shares of CRH Medical by 65.3% in the third quarter. TD Asset Management Inc. now owns 111,054 shares of the company’s stock valued at $289,000 after acquiring an additional 43,851 shares in the last quarter. JPMorgan Chase & Co. grew its stake in shares of CRH Medical by 69.1% in the third quarter. JPMorgan Chase & Co. now owns 410,100 shares of the company’s stock valued at $964,000 after acquiring an additional 167,600 shares in the last quarter. Finally, Stifel Financial Corp grew its stake in shares of CRH Medical by 7.7% in the third quarter. Stifel Financial Corp now owns 1,665,839 shares of the company’s stock valued at $4,332,000 after acquiring an additional 119,685 shares in the last quarter.

Shares of CRHM stock remained flat at $$2.60 on Wednesday. The company’s stock had a trading volume of 73,500 shares, compared to its average volume of 103,256. CRH Medical has a fifty-two week low of $1.46 and a fifty-two week high of $9.25. The firm has a market cap of $229.48, a price-to-earnings ratio of 28.89 and a beta of 1.14.

TRADEMARK VIOLATION WARNING: This report was first reported by Ticker Report and is owned by of Ticker Report. If you are accessing this report on another domain, it was stolen and reposted in violation of U.S. & international copyright legislation. The legal version of this report can be read at https://www.tickerreport.com/banking-finance/3302926/crh-medical-corp-crhm-receives-5-92-average-pt-from-analysts.html.

CRH Medical Company Profile

CRH Medical Corporation is a Canada-based healthcare products and services company. The Company focused on providing physicians with services and products for the treatment of gastrointestinal diseases. The Company also provides anesthesiology services to gastroenterologists in the United States through its subsidiaries.

Analyst Recommendations for CRH Medical (NYSEAMERICAN:CRHM)

Receive News & Ratings for CRH Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Gilead Sciences  Upgraded to “Buy” by Zacks Investment Research
Gilead Sciences Upgraded to “Buy” by Zacks Investment Research
Electronics for Imaging  Upgraded to Hold by BidaskClub
Electronics for Imaging Upgraded to Hold by BidaskClub
CommerceHub  Downgraded by BidaskClub to “Sell”
CommerceHub Downgraded by BidaskClub to “Sell”
First Federal Bancshares of Arkansas  Lowered to “Sell” at BidaskClub
First Federal Bancshares of Arkansas Lowered to “Sell” at BidaskClub
ADTRAN  Given “Buy” Rating at Needham & Company LLC
ADTRAN Given “Buy” Rating at Needham & Company LLC
Deckers Outdoor Co.  Expected to Announce Earnings of $0.18 Per Share
Deckers Outdoor Co. Expected to Announce Earnings of $0.18 Per Share


© 2006-2018 Ticker Report. Google+.